Intended for contraception to manage reproductive hormones and support pregnancy prevention.
Mechanism of Action
This combined oral contraceptive suppress ovulation primarily by inhibiting gonadotropin secretion. It also induces changes in cervical mucus and the endometrium that impede sperm transport and egg implantation.
Route of Administration
Oral
Onset Time
2–4 days
Duration
24 hours
Contraindications
History of thromboembolic disorders, Breast cancer, Heavy smoking over age 35, Pregnancy
Severe Adverse Events
Deep vein thrombosis, Pulmonary embolism, Stroke — requires immediate medical attention
Common Side Effects
Nausea, Headache, Breast tenderness
Uncommon Side Effects
Weight changes, Mood fluctuations, Spotting
Drug Interactions
Alcohol, Tobacco, Rifampin, St. John's Wort, Phenobarbital
Pregnancy Safety Warnings
FDA Category X: Strictly contraindicated in pregnancy. Breastfeeding: Excreted in milk; not recommended.
Information related to Desogestrel with Ethinyl Estradiol is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
